Literature DB >> 20816407

Epidemiology of headache.

Gian Camillo Manzoni1, Lars Jacob Stovner.   

Abstract

Epidemiological studies conducted in the general population point to average headache prevalence rates of 46% for 1-year prevalence and of 64% for lifetime prevalence. For migraine, most studies conducted in the adult general population of western Europe and North America indicate rates between 5% and 9% in men, and between 12% and 25% in women. Non-western countries report lower figures. Migraine shows no gender differences in children, while in the elderly its frequency appears much reduced in both genders. About one-third of migraineurs suffer from migraine with aura. For tension-type headache, prevalence data reports in the literature are few and conflicting: rates range from 11% in Singapore to 20-40% in the USA and over 80% in Denmark. It is worth noting that the highest figures are found in studies where a personal interview has been employed. This probably indicates that the prevalence of this headache subtype is particularly sensitive to the method of data collection. Cluster headache occurs in 1-3 per thousand of the general population, with a gender (M:F) ratio of about 3:1. About 4% of the adult general population suffers from chronic daily headache.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20816407     DOI: 10.1016/S0072-9752(10)97001-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  26 in total

1.  Height intolerance: an underrated threat.

Authors:  Thomas Brandt; Michael Strupp; Doreen Huppert
Journal:  J Neurol       Date:  2011-09-17       Impact factor: 4.849

2.  A meta-analysis of voxel-based morphometric studies on migraine.

Authors:  Wenting Hu; Jian Guo; Ning Chen; Jiang Guo; Li He
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Prevention, education and counselling: the worldwide role of the community pharmacist as an epidemiological sentinel of headaches.

Authors:  Francesca Baratta; Gianni Allais; Sara Rolando; Gian Camillo Manzoni; Gennaro Bussone; Chiara Benedetto; Cecilia Scarinzi; Roberto Gnavi; Teresa Spadea; Giuseppe Costa; Marco Parente; Massimo Mana; Mario Giaccone; Andrea Mandelli; Paola Brusa
Journal:  Neurol Sci       Date:  2019-05       Impact factor: 3.307

Review 4.  Our evolving understanding of migraine with aura.

Authors:  Justin M DeLange; F Michael Cutrer
Journal:  Curr Pain Headache Rep       Date:  2014-10

5.  Identification of Allodynic Migraine Patients with the Turkish Version of the Allodynia Symptom Checklist: Reliability and Consistency Study.

Authors:  Osman Özgür Yalin; Derya Uludüz; Mehmet Ali Sungur; Hande Sart; Aynur Özge
Journal:  Noro Psikiyatr Ars       Date:  2016-04-15       Impact factor: 1.339

6.  Utilization of a neurology specialty service by primary care providers for headache management at a tertiary care hospital.

Authors:  Samra Vazirian; Travis Ho; Rick A Weideman; Meagen R Salinas; Paul W Hurd; Olaf Stuve
Journal:  J Cent Nerv Syst Dis       Date:  2022-07-13

Review 7.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

Review 8.  Breastfeeding and migraine drugs.

Authors:  Riccardo Davanzo; Jenny Bua; Giulia Paloni; Giulia Facchina
Journal:  Eur J Clin Pharmacol       Date:  2014-09-13       Impact factor: 2.953

9.  Prediagnostic symptoms and signs of adult glioma: the patients' view.

Authors:  Marthe C M Peeters; Linda Dirven; Johan A F Koekkoek; Ellen G Gortmaker; Lara Fritz; Maaike J Vos; Martin J B Taphoorn
Journal:  J Neurooncol       Date:  2020-01-01       Impact factor: 4.130

10.  Primary headache in the elderly in South-East Asia.

Authors:  Mei-Ling Sharon Tai; Jaishree Sharmini Jivanadham; Chong Tin Tan; Vijay K Sharma
Journal:  J Headache Pain       Date:  2012-03-16       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.